French drugmaker Sanofi looks to spin off its consumer business in India

The leading vaccine maker is working with Bank of America on the demerger process, said the people cited above. About 60% of Sanofi India is owned by Sanofi and wholly owned subsidiary Hoechst Gmbh. The rest is held by foreign and domestic institutional investors along with retail investors.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/AJ35IEf
via IFTTT